# To Evaluate the Safety and Pharmacokinetics of BMS-986177 in Healthy Japanese Participants

> **NCT03224260** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 33 (actual)

## Conditions studied

- Thrombosis

## Interventions

- **DRUG:** BMS-986177
- **OTHER:** Matched Placebo

## Key facts

- **NCT ID:** NCT03224260
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-28
- **Primary completion:** 2017-11-07
- **Final completion:** 2017-11-07
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2018-06-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03224260

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03224260, "To Evaluate the Safety and Pharmacokinetics of BMS-986177 in Healthy Japanese Participants". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03224260. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*